Risk of lactic acidosis in type 2 diabetes patients using metformin: A case control study.
Metformin constitutes first-line treatment of type 2 diabetes mellitus. It is presumed to have lactic acidosis as a dangerous, but rare, side effect.To estimate the incidence rate of lactic acidosis in patients with type 2 diabetes mellitus as well as to estimate the relative risk of lactic acidosis...
Main Authors: | Abdellatif Aharaz, Anton Pottegård, Daniel Pilsgaard Henriksen, Jesper Hallas, Henning Beck-Nielsen, Annmarie Touborg Lassen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5940216?pdf=render |
Similar Items
-
Risk factors for hospitalization due to community-acquired sepsis - a population-based case-control study.
by: Daniel Pilsgaard Henriksen, et al.
Published: (2015-01-01) -
How well do discharge diagnoses identify hospitalised patients with community-acquired infections?--a validation study.
by: Daniel Pilsgaard Henriksen, et al.
Published: (2014-01-01) -
Prognosis and risk factors for deterioration in patients admitted to a medical emergency department.
by: Daniel Pilsgaard Henriksen, et al.
Published: (2014-01-01) -
Metformin-Associated Lactic Acidosis
by: Sunghwan Suh
Published: (2015-03-01) -
Lactic acidosis associated to metformin
by: María Juliana Zavala Portugal, et al.
Published: (2017-06-01)